The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 21, 2026
Filed:
Mar. 30, 2021
Applicants:
Minovia Therapeutics Ltd., Tirat Hacarmel, IL;
Tel Hashomer Medical Research Infrastructure and Services Ltd., Ramat Gan, IL;
Inventors:
Natalie Yivgi-Ohana, Haifa, IL;
Noa Sher, Haifa, IL;
Moriya Blumkin, Tel Aviv, IL;
Elad Jacoby, Ramat Gan, IL;
Assignees:
Minovia Therapeutics Ltd., Tirat Hacarmel, IL;
Tel Hashomer Medical Research Infrastructure and Services Ltd., Ramat Gan, IL;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/545 (2015.01); A61K 38/17 (2006.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/42 (2025.01); C12N 5/0783 (2010.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
A61K 35/545 (2013.01); A61K 38/1774 (2013.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/4211 (2025.01); C12N 5/0636 (2013.01); C12N 15/86 (2013.01); C12N 2502/025 (2013.01); C12N 2740/10043 (2013.01);
Abstract
The present invention is based on the discovery that cells enriched with mitochondria are useful for treating diseases and disorders. Disclosed are pharmaceutical compositions of mitochondrially-enriched genetically engineered T cells and methods of treatment using mitochondrially-enriched genetically engineered T cells.